Tirzepatide, a recently approved medication, is sparking significant interest in the scientific community as a viable treatment for both diabetes, type 2 and reducing body fat. This dual-action drug works by activating two different receptors, GLP-1 and GIP, leading to better glycemic management and notable fat loss in research studies . While prel